Skip to main content
. 2018 Oct 31;10(11):415. doi: 10.3390/cancers10110415

Figure 5.

Figure 5

Progression Free Survival (PFS) curves according to the percentage of TIM-3+ ME cells of cHL patients (n = 37), with cutoff of 10% of ME immune cells positive (p = 0.006).